Randomized, double-blind, multicenter safety and efficacy study of rifalazil compared with azithromycin for treatment of uncomplicated genital Chlamydia trachomatis infection in women

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 7, 2014, Pages 4014-4019

  Geisler, William M ^a   Pascual, Maria Luz G ^b   Mathew, Judy ^b   Koltun, William D ^c   Morgan, Franklin ^d   Batteiger, Byron E ^e   Mayes, Annette ^f   Tao, Sijia ^g   Hurwitz, Selwyn J ^g   Sayada, Chalom ^h   Schinazi, Raymond F ^g  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b RFS Pharma LLC   (United States)

^c Medical Center for Clinical Research   (United States)

^d Emergency Physicians of Tidewater   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Office of Annette Mayes MD   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ActivBiotics Pharma   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; RIFALAZIL; ANTIINFECTIVE AGENT; RIFAMYCIN;

ABDOMINAL PAIN; ADULT; ARTICLE; ASTHENIA; CHLAMYDIASIS; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FEMALE; FEMALE GENITAL TRACT INFECTION; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT OUTCOME; UPPER ABDOMINAL PAIN; VAGINITIS; VOMITING; BIOASSAY; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; COMPARATIVE STUDY; GENITAL DISEASES, FEMALE; MICROBIOLOGY; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; RIFAMYCINS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903130176     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02521-14     Document Type: Article

References (17)

1. Centers for Disease Control and Prevention. 2011. Sexually transmitted disease surveillance (reported in 2012). CDC, U.S. Department of Health and Human Services, Atlanta, Georgia. http://www.cdc.gov/std/stats12/Surv2012.pdf.
2. Nyirjesy P. 2001. Nongonococcal and nonchlamydial cervicitis. Curr. Infect. Dis. Rep. 3:540-545. http://dx.doi.org/10.1007/s11908-001-0092-6.
3. Centers for Disease Control and Prevention. 2010. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommend. Rep. 59(RR-12):1-116.
4. Lau C-Y, Qureshi AK. 2002. Azithromycin versus doxycycline for genital chlamydial infections: a meta analysis of randomized clinical trials. Sex. Transm. Dis. 29:497-502. http://dx.doi.org/10.1097/00007435-200209000-00001. (Pubitemid 35001337)
5. Batteiger BE, Tu W, Ofner S, Van Der Pol B, Stothard DR, Orr DP, Katz BP, Fortenberry JD. 2010. Repeated Chlamydia trachomatis genital infections in adolescent women. J. Infect. Dis. 201:42-51. http://dx.doi.org/10.1086/648734.
6. Schwebke JR, Rompalo A, Taylor S, Sena AC, Martin DH, Lopez LM, Lensing S, Lee JY. 2011. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens - a randomized clinical trial. Clin. Infect. Dis. 52:163-170. http://dx.doi.org/10.1093/cid/ciq074.
7. Golden MR, Whittington WLH, Handsfield HH, Hughes JP, Stamm WE, Hogben M, Clark A, Malinski C, Helmers JRL, Thomas KK, Holmes KK. 2005. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N. Engl. J. Med. 352:676-685. http://dx.doi.org/10.1056/ NEJMoa041681. (Pubitemid 40239215)
8. Hosenfeld CB, Workowski KA, Berman S, Zaidi A, Dyson J, Mosure D, Bolan G, Bauer HM. 2009. Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature. Sex. Transm. Dis. 36:478-489. http://dx.doi.org/10.1097/OLQ.0b013e3181a2a933.
9. Xu F, Stoner BP, Taylor SN, Mena L, Tian LH, Papp J, Hutchins K, Martin DH, Markowitz LE. 2011. Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials. Obstet. Gynecol. 118:231-239. http://dx.doi.org/10.1097/AOG. 0b013e3182246a83.
10. Warner Chilcott. 2013. Doryx (doxycycline hyclate delayed-release tablets). Physician prescribing information. http://www.doryx.com/pdf/pi-doryx- tablet.pdf.
11. Rothstein DM, Van Duzer J, Sternlicht A, Gilman SC. 2007. Rifalazil and other benzoxazinorifamycin in the treatment of chlamydia-based persistent infections. Arch. Pharm. (Weinheim) 340:517-529. http://dx.doi.org/10.1002/ardp. 200700080. (Pubitemid 350007049)
12. Stamm WE, Geisler WM, Suchland RJ. 2002. Assessment of antimicrobial resistance in Chlamydia trachomatis strains associated with treatment failure or same strain recurrence, p 353-360. In Chlamydial infections: Proceeding of the 10th International Symposium on Human Chlamydial Infections, Antalya, Turkey.
13. Kohlhoff SA, Roblin PM, Reznik T, Hawser S, Islam K, Hammerschlag R. 2004. In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae. Antimicrob. Agents Chemother. 48:1885-1886. http://dx.doi.org/10.1128/AAC.48.5.1885-1886.2004. (Pubitemid 38544405)
14. Stamm WE, Batteiger BE, McCormack WM, Totten PA, Sternlicht A, Kivel NM, Rifalazil Study Group. 2007. A randomized, double-blind study comparing single-dose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men. Sex. Transm. Dis. 34:545-552. http://dx.doi.org/10.1097/01.olq.0000253348.44308.8c. (Pubitemid 47207142)
15. Larsson M, Michaelis AF, Zhu Y, Ramu K. 2007. Determination of rifalazil, a potent antibacterial agent, in human plasma by liquid-liquid extraction and LC-MS/MS. J. Chromatogr. B. Analyt Technol Biomed Life Sci. 859:103-110. http://dx.doi.org/10.1016/j.jchromb.2007.09.013. (Pubitemid 350001272)
16. Pfizer. 2013. Zithromax (azithromycin) physician prescribing information. http://labeling.pfizer.com/ShowLabeling.aspx?id=511.
17. Chen YX, Cabana B, Kivel N, Michaelis A. 2007. Effect of food on the pharmacokinetics of rifalazil, a novel antibacterial, in healthy male volunteers. J. Clin. Pharmacol. 47:841-849. http://dx.doi.org/10.1177/ 0091270007300745.